Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Werewolf Therapeutics (HOWL) Gets a Buy from Bank of America Securities
Bank of America Securities analyst Jason Zemansky reiterated a Buy rating on Werewolf Therapeutics (HOWL – Research Report) today and set a ...
American Association of Individual Investors7h
Which Is a Better Investment, Jazz Pharmaceuticals plc or Johnson & Johnson Stock?
Learn more about whether Jazz Pharmaceuticals plc or Johnson & Johnson is a better investment based on AAII's A+ Investor ...
pharmaphorum5d
Jazz adds first immuno-oncology drug via $1.3bn Werewolf deal
Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma ...
pharmaphorum3d
Jazz and Zymeworks enter exclusive zanidatamab agreement
In what is a further expansion of Jazz’s oncology portfolio – following a $1.3 billion licensing agreement with Werewolf Therapeutics earlier this year to acquire its first immuno-oncology ...
The Manila Times1d
Regenx Announces Non-Brokered Financing for Gross Proceeds of $679,032
Regenx Tech is a cleantech, urban mining company that recycles end-of-life diesel catalytic converters using its innovative ...
Yahoo Finance4d
Candel Therapeutics, Inc. (CADL)
At close: March 28 at 4:00:01 PM EDT ...